Video Experimental Relacionado

Updated: Sep 10, 2025

Acupoint Needle-Embedding Combined with Ironing Therapy for Postoperative Pain After Anal Surgery

Acupoint Needle-Embedding Combined with Ironing Therapy for Postoperative Pain After Anal Surgery

Published on: June 23, 2023

Mejorar los resultados de las hemorroides: una revisión narrativa y una guía de mejores prácticas para los

Nardine Nakhla¹, Ashok Hospattankar², Kamran Siddiqui²

¹Professional Practice Department, School of Pharmacy, University of Waterloo, 200 University Ave. W., Waterloo, ON N2L 3G1, Canada.

Pharmacy (Basel, Switzerland)

|August 27, 2025

Resumen

Los farmacéuticos pueden mejorar el cuidado de las hemorroides adoptando nuevas pautas y herramientas digitales para una mejor evaluación y tratamiento del paciente. Esto mejora los resultados y la calidad de vida de las personas con enfermedad hemorroidal.

Área de la Ciencia:

Farmacología
Farmacia clínica
Gastroenterología

Sus antecedentes:

La enfermedad hemorroidal es común, causando costos de atención médica significativos.
La administración actual se enfrenta a desafíos en la educación del paciente, la detección temprana y la elección del tratamiento.
El papel de los farmacéuticos se está expandiendo en el tratamiento de las hemorroides.

Objetivo del estudio:

Proporcionar a los farmacéuticos información actualizada sobre el tratamiento de las hemorroides basado en la evidencia.
Introducir algoritmos de evaluación estructurados para la evaluación estandarizada de los síntomas.
Empoderar a los farmacéuticos para cerrar brechas en la atención al paciente y optimizar las vías de tratamiento.

Principales métodos:

Revisión narrativa de la literatura y las directrices actuales.
Incorporación de las directrices de la Sociedad Estadounidense de Cirujanos de Colón y Recto (ASCRS) para el año 2024.
Integración de plataformas digitales de apoyo a la toma de decisiones y algoritmos de evaluación estructurados.

Principales resultados:

La evidencia emergente apoya el uso de flebotónica para el tratamiento de los síntomas.
Las herramientas digitales mejoran la capacidad de los farmacéuticos para evaluar los síntomas y clasificar a los pacientes con precisión.
Los farmacéuticos pueden evaluar sistemáticamente los síntomas, identificar señales de alerta y mejorar la toma de decisiones.

Conclusiones:

Los farmacéuticos son fundamentales para mejorar el cuidado de las hemorroides debido a su accesibilidad y papel de confianza.
La adopción de directrices actualizadas y herramientas novedosas puede mejorar los resultados del tratamiento y la seguridad del paciente.
Los farmacéuticos pueden mejorar significativamente la calidad de vida de los pacientes con enfermedad hemorroidal.

Palabras clave:

Discomodidad anorectal Adstringentes Algoritmo clínico Salud digital las hemorroides Tratamiento sin receta asesoramiento al paciente sangrado rectal

Más Videos Relacionados

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Videos de Conceptos Relacionados

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...